| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 25.18▼ | 25.18▼ | 25.19▼ | 25.03▼ | 25.12▼ |
| MA10 | 25.20▼ | 25.20▼ | 25.11▼ | 25.11▼ | N/A |
| MA20 | N/A | N/A | N/A | 25.14▼ | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | 63.128▲ | N/A | N/A | 45.613▼ | N/A |
| STOCH | N/A | N/A | N/A | 12.668▼ | N/A |
| WILL %R | -69.697 | N/A | N/A | -80.645▼ | N/A |
| CCI | -57.512 | N/A | N/A | -94.801 | N/A |
|
Wednesday, April 29, 2026 03:25 AM
Biotech company Biogen (NASDAQ:BIIB) reported in Q1 CY2026, with sales up 1.9% year on year to $2.48 billion. Its non-GAAP profit of $3.57 per share was 20.9% above analysts’ consensus estimates. Is ...
|
|
Tuesday, April 28, 2026 10:46 PM
Biotech company Biogen (NASDAQ:BIIB) will be reporting results this Wednesday before the bell. Here’s what you need to know.
|
|
Sunday, April 26, 2026 11:05 PM
Biogen Inc. (NASDAQ:BIIB) is one of the best stem cell therapy stocks to buy. On April 22, Biogen Inc. (NASDAQ:BIIB) was upgraded to Buy from Neutral by UBS, with the firm adjusti ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/05/26 | 25.02 | 25.06 | 25.02 | 25.03 | 3,129 |
| 04/05/26 | 25.02 | 25.02 | 24.97 | 25.00 | 7,425 |
| 01/05/26 | 25.0701 | 25.08 | 25.05 | 25.05 | 1,281 |
| 30/04/26 | 25.02 | 25.05 | 25.0199 | 25.0371 | 6,580 |
| 29/04/26 | 25.10 | 25.10 | 25.0495 | 25.0495 | 12,067 |
| 28/04/26 | 25.17 | 25.17 | 25.10 | 25.14 | 3,507 |
| 27/04/26 | 25.1598 | 25.16 | 25.15 | 25.16 | 17,665 |
| 24/04/26 | 25.15 | 25.20 | 25.15 | 25.20 | 10,459 |
| 23/04/26 | 25.20 | 25.215 | 25.17 | 25.17 | 29,778 |
| 22/04/26 | 25.23 | 25.24 | 25.23 | 25.235 | 292 |
|
|
||||
|
|
||||
|
|